Skip to main content

Allergan reports mixed results for Q2


IRVINE, Calif. Drug maker Allergan had mixed results during second quarter 2009, according to an earnings release Friday.

The Irvine, Calif.-based company reported diluted earnings per share of 58 cents, compared to 47 cents in second quarter 2008.

At the same time, total product net sales were $1.1 billion, a 3.2% decrease, compared with second quarter 2008 thanks to currency exchange rates, while net sales of specialty pharmaceuticals decreased by 0.6%. Medical device net sales decreased by 14%.

This ad will auto-close in 10 seconds